SEVER Matjaz | Department of Leukemia, M.D. Anderson Cancer Center
スポンサーリンク
概要
Department of Leukemia, M.D. Anderson Cancer Center | 論文
- Imatinib mesylate therapy for polycythemia vera : final result of a phase II study initiated in 2001
- The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2^ mutation
- Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406
- Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells